佐力药业（300181）8月13日主力资金净流出1030.98万元

Group 1 - The core viewpoint of the news is that Zhaoli Pharmaceutical's stock price has experienced a slight decline, while the company has shown significant revenue and profit growth in its latest quarterly report [1][3] - As of August 13, 2025, Zhaoli Pharmaceutical's stock closed at 20.01 yuan, down 0.4%, with a turnover rate of 2.59% and a trading volume of 156,200 hands, amounting to a transaction value of 312 million yuan [1] - The company's latest quarterly performance report indicates total operating revenue of 824 million yuan, a year-on-year increase of 22.52%, and a net profit attributable to shareholders of 181 million yuan, up 27.20% year-on-year [1] Group 2 - The company has a current ratio of 2.011, a quick ratio of 1.619, and a debt-to-asset ratio of 30.38%, indicating a strong liquidity position [1] - Zhaoli Pharmaceutical has made investments in 10 external enterprises and participated in 4,955 bidding projects, showcasing its active engagement in the market [2] - The company holds 100 trademark registrations and 33 patents, along with 163 administrative licenses, reflecting its commitment to intellectual property and regulatory compliance [2]